Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mehmet Baykara has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Superficial Retinal Vascular Network Morphology and Sectoral RNFL Thickness in Children with a History of Bilateral Congenital Cataract Surgery: An Exploratory OCT/OCTA Study

    by Mehmet Omer Kiristioglu, Ahmet Tuncer Ozmen, Meral Yildiz, Ahmet Akcan, Esin Sogutlu Sari, Mehmet Baykara

    Background: Whether congenital cataract-related visual deprivation and subsequent rehabilitation are associated with retinal structural and vascular network differences remains unclear. This study evaluated superficial retinal vascular network descriptors and retinal nerve fiber layer (RNFL) thickness in children after bilateral congenital cataract extraction and secondary intraocular lens implantation. Methods: Age-matched children served as controls. Participants underwent spectral-domain optical coherence tomography (OCT) and 6 × 6 mm optical coherence tomography angiography (OCTA). Metrics were magnification-corrected, and comparisons used generalized estimating equation models adjusted for age, eye side, axial length, and spherical equivalent. Results: Eighteen pseudophakic children (36 eyes; median age, 8 years) and 17 controls (34 eyes; median age, 9 years) were included. In adjusted models, macular mean vessel diameter was higher in pseudophakic eyes (β = 11.16 µm; p = 0.003), as was macular mean tortuosity (β = 0.032; p = 0.001). Branchpoint density was lower in direction but not independently significant (p = 0.125). Choroidal thickness, choroidal vascularity index, and foveal avascular zone area did not differ significantly. Temporal RNFL thickness was greater in pseudophakic eyes (β = 13.37 µm; p = 0.007); other RNFL parameters were not significant. Conclusions: These findings suggest exploratory differences in superficial vascular network morphology and temporal RNFL thickness. However, because the groups differed clinically in best-corrected visual acuity, refractive status, and axial length, residual confounding cannot be excluded despite magnification correction and adjusted modeling.

  • Open Access

    Visual Outcomes at 12 Months in Patients Following Implantation of a Diffractive Multifocal Intraocular Lens

    by Mehmet Baykara, Yonca Aydin Akova, Osman Sevki Arslan, Necdet Cinhuseyinoglu, Tamer Takmaz, Ahmet Gucukoglu, Yildirim Beyazit Usta

    The aim of this study was to assess distance, intermediate, and near visual acuity, contrast sensitivity, and patient satisfaction outcomes of a multifocal intraocular lens (IOL). This multicenter, prospective clinical study was conducted at seven study sites in Turkey. Patients who underwent bilateral cataract removal and implantation of a diffractive, acrylic, hydrophobic, multifocal IOL (Acriva UD Reviol MFB 625; VSY Biotechnology, Istanbul, Turkey) were included. The uncorrected and best corrected distance visual acuities (UCDVA and BCDVA), uncorrected and best corrected intermediate visual acuities (UCIVA and BCIVA), and uncorrected and best corrected near visual acuities (UCNVA and BCNVA) were measured preoperatively and at postoperative 1, 6, and 12 months. Distance and near visual acuity scores (VAS) contrast sensitivities were measured at these time points. Quality of life was evaluated by visual function-14 (VF-14) questionnaire. Two hundred eyes of 100 patients were included. Monocular and binocular visual acuities at all distances showed improvement at postoperative 12 months compared to preoperative measurements (P < 0.001). Monocular and binocular UCIVA and binocular BCIVA at postoperative 12 months were significantly improved compared to measurements at 1 month (P < 0.001). Binocular contrast sensitivity at distance showed significant improvement from postoperative 1 month to postoperative 12 months, except for 3 cycles per degree (cpd; without glare) and 18 cpd (with glare). VAS improved from 75.96 at postoperative 1 month to 76.85 at postoperative 12 months. VF-14 score was 98.2 ± 4.6. The Acriva UD Reviol MFB 625 appears to provide a good level of distance and near visual acuity, quality of life, and patient satisfaction. Further studies with longer follow-up will provide valuable insight into the long-term stability of these visual outcomes.